Yonker, Lael MLael MYonkerSwank, ZoeZoeSwankBartsch, Yannic CYannic CBartschBurns, Madeleine DMadeleine DBurnsKane, AbigailAbigailKaneBoribong, Brittany PBrittany PBoribongDavis, Jameson PJameson PDavisLoiselle, MaggieMaggieLoiselleNovak, TanyaTanyaNovakSenussi, YasmeenYasmeenSenussiCHI-AN CHENGBurgess, EleanorEleanorBurgessEdlow, Andrea GAndrea GEdlowChou, JanetJanetChouDionne, AudreyAudreyDionneBalaguru, DuraisamyDuraisamyBalaguruLahoud-Rahme, ManuellaManuellaLahoud-RahmeArditi, MosheMosheArditiJulg, BorisBorisJulgRandolph, Adrienne GAdrienne GRandolphAlter, GalitGalitAlterFasano, AlessioAlessioFasanoWalt, David RDavid RWalt2023-02-012023-02-012023-01-040009-73221524-4539https://scholars.lib.ntu.edu.tw/handle/123456789/627502Cases of adolescents and young adults developing myocarditis after vaccination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-targeted mRNA vaccines have been reported globally, but the underlying immunoprofiles of these individuals have not been described in detail.enCOVID-19; mRNA vaccine; myocarditis; spike protein, SARS-CoV-2journal issue10.1161/CIRCULATIONAHA.122.06102536597886